-
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 12:00 GMT
… . (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives … .
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives …
-
Polaris International Equity Composite Q1 2024 Commentary
25 Apr 2024 13:45 GMT
… ), a Japanese-based global pharmaceutical company, with a diversified product portfolio that branches …
-
IBN Coverage Initiated for Nutriband Inc.
25 Apr 2024 11:00 GMT
… – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on … experts to serve our increasingly diversified list of clients. Through our …
-
Laboratorios Farmaceuticos Rovi S A : ROVI announces agreement to manufacture pre-filled syringes
25 Apr 2024 08:17 GMT
… syringes for a global pharmaceutical company
Production will take … quot;), a pan-European pharmaceutical company that specialises and engages … is a pan-European pharmaceutical company that specialises and … Poland and has a diversified marketing portfolio of …
-
News24 | Investment update | Meta’s $360 billion rally to collide with lofty AI expectations
25 Apr 2024 06:29 GMT
… .8% and 1.3%, respectively.
Diversified miners, Anglo American, Kumba Iron … .8% and 1.5%, respectively.
Pharmaceutical companies, Aspen Pharmacare, Life Healthcare and …
-
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
25 Apr 2024 02:11 GMT
… . The company has established a diversified R&D pipeline comprising … social responsibilities of a Chinese pharmaceutical company through its involvement in developing …
-
CORRECTING and REPLACING PharmaEssentia Appoints Robert Geller, M.D. as Head of Medical
24 Apr 2024 17:11 GMT
… one approved product and a diversifying pipeline. Founded in 2003 by … from U.S. biotechnology and pharmaceutical companies, today PharmaEssentia is expanding its …
-
Alexandria Real Estate Equities, Inc. (NYSE:ARE) Q1 2024 Earnings Call Transcript
24 Apr 2024 15:32 GMT
… , are our multinational our multinational pharmaceutical companies, which represent 20% ARR. M … real estate partnerships looking to diversify their asset mix with life …
-
MK Party's manifesto: Jacob Zuma's plan to fix SA
24 Apr 2024 14:30 GMT
… them towards funding economic diversification and technological upgrading.
- … capacity in existing universities, diversifying programme offerings, enhancing online … are not exploited by capitalist pharmaceutical companies.
- Institutionalize the research …
-
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
24 Apr 2024 11:18 GMT
… , through its affiliate, La Jolla Pharmaceutical Company, include GIAPREZA® (angiotensin II), … , Inc.
Innoviva is a diversified holding company with a core … uncomplicated gonorrhea, and La Jolla Pharmaceutical Company, including GIAPREZA® (angiotensin II), …